Innovative Research of America(IRA) 是一家致力研发于药物定量定时缓释系统的专业化公司，又称Matrix-Driven Delivery (MDD) 给药系统。该给药系统由一个可生物吸收的基质组成，含有定量可控的活性给药成分，可以以设定的剂量在一定时间范围内进行给药。

Since it is not easy to administer drugs and hormones orally to research animals, several delivery methods have been devised as alternatives.  However, most scientists continue to labor with unreliable injectables to conduct their research.

Matrix-Driven Delivery (MDD) Pellet（MDD片剂）的优势

Saves time

Ready-to-implant

Insures controlled product release over time

Avoids "peak and valley" effects

Guarantees consistent product preparation

Extends product life against spontaneous breakdown

Extends product life against host-related breakdown

Minimizes experimental variables

Insures safety of the experimenter

Reduces neurophysiological trauma to animal/no excessive handling

Generates more meaningful and reproducible results

Superior to conventional delivery methods

Enhances experimental efficiency

Frees valuable time for creative research

Saves money

Innovative Research of America的主要产品包括：

ANTIBIOTICS

ANTI-INFLAMMATORY AGENTS

ANTI-NEOPLASTICS

CATECHOLAMINES & RELATED PRODUCTS

CORTICOIDS & DIURETICS

ESTROGENS & ANTI-ESTROGENS

FATTY ACIDS

MISCELLANEOUS PRODUCTS

NUCLEOTIDE RELATED PRODUCTS

PLACEBO

PROGESTINS

PROSTAGLANDINS

THYROIDS

VITAMINS

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技特约代理Aviscera Bioscience全系列产品。

Aviscera Bioscience是一家领先的销售有特色的用于代谢综合症和心血管疾病研究的肌肉因子和细胞因子的供应商。主要产品类别：用于心血管疾病、骨质疏松、肾脏损伤/肾功能衰竭、感染和败血症、代谢综合症、癌症/肿瘤、阿尔茨海默氏症、慢性阻塞性肺病和肺纤维化、哮喘的生物标志物ELISA试剂盒。产品包括很多哺乳动物肌肉因子和细胞因子的ELISA试剂盒及其相应的无标记及标记的抗体和重组蛋白。

Leading Supplier of Specialty Adipokines, Myokines and Cytokines for Metabolic Syndrome & Cardiovascular Diseases Research.

Aviscera Bioscience的主要产品包括：

New Human CTRP15/Myonectin ELISA Kits

New Soluble NRG4 ELISA Kits

New Renin (Total) (Human) ELISA Kits and Proteins

New Stanniocalcin-1 (Human) ELISA Kits

New human CTRP6 ELISA Kit

New Anti Human Soluble ST2 Monoclonal Antibodies for ST2 Immunoassay Development

Anti VGF antibodies validated on WB

IL-17 Receptor A & D ELISA Kits

Stathmin 1/Metabolastin ELISA, Antibody Recombinant

IL-37 ELISA, Antibody Recombinant Proteins

Updated FGF-23 (Human) ELISA Kit

New VEGFR3/FLT-4 (Human) ELISA Kits

Updated Irisin (Human) ELISA Kit

Human Azurocidin/CAP37 ELISA Kit

New Neurotrimin (NTM) rec

cAMP Assay Kit

New HE4/WFDC2/WAP5 ELISA Kit

New IL-18R1, IL-18RAP ELISA Kits

Elafin/PI3/WFDC14 ELISA Kit

Soluble CD112 ELISA for serum or plasma samples

New APOA-IV (Human) ELISA Kit

New Soluble CD305 ELISA Kits

New Soluble Neprilysin (Human) ELISA Kits

New Human SPARC ELISA Kit

New Anti Human Galectin-3 Monoclonal Antibodies for Galectin-3  Immunoassay

New updated mouse serum albumin ELISA Kit

New Soluble CD14 Ultrasensitive ELISA Kits

New Adipsin (Human) ELISA Kit

Updated Irisin (Human) ELISA Kit

Updated Neprilysin /CD10 (Human) ELISA Kit

Updated MPF (Human) ELISA Kit

Soluble Arginase 1 (Human) ELISA Kit

Heart Cadherin / T-Cadherin ELISA Kit

Soluble Neuregulin-4 elisa kit 

New Mouse CTRP4 Rec

New irisin elisa kit with HEK293 derived standard and new monoclonal antibodies

Asprosin Monoclonal Antibody

New Active IL-29 (Human) ELISA Kit

Soluble ACVRL1 ELISA Kit

等

Celprogen是一家生物技术公司，为心脏病学、肿瘤学、糖尿病和神经病学的再生医学研发干细胞研究和治疗产品。Celprogen的所有生物产品，包括干细胞、癌症干细胞、IPC和包括ECM在内的培养基，均在美国制造和生产。

CELPROGEN is a biotechnology company developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media including ECM’s, are manufactured and produced in the United States of America. CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, Invitro diagnostics and academic partnership for drug discovery.

Celprogen公司的主要产品：

3D Culture Systems

Biological Reagents

Cell-Based Assay Kits

Cosmetic

Devices

ExtracellularMatrix

Human Serum Albumin (HSA)

Life Science

Normal Cells

Organ Cultures

Patient-Derived Xenografts [PDX]

Therapeutics

Tumorgenicity

Vaccine Development

Xeno-Free Media